Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Clasificación en acciones
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Precio por acción
$8.03
Capitalización bursátil
$6.31B
Cambio (1 día)
1.07%
Cambio (1 año)
-8.04%
País
CN
Comercio Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Categoría
Healthcare
Historial de dividendos de Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Shenzhen New Industries Biomedical Engineering Co., Ltd. (símbolo bursátil: 300832) realizó un total de 7 pagos de dividendos.
La suma de todos los dividendos (ajustados por splits de acciones) es: $6.12
Rentabilidad por dividendo (TTM): 0.0224
La suma de todos los dividendos (ajustados por splits de acciones) es: $6.12
Rentabilidad por dividendo (TTM): 0.0224
Pagos de dividendos de Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) desde 2020 hasta 2026
Pagos anuales de dividendos
| Año | Dividendo (ajustado por splits de acciones) | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | 14.00% |
| 2021 | $0.5263 | -33.34% |
| 2020 | $0.7895 | 0.00% |
Lista de todos los pagos de dividendos
| Año | Dividendo | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | -40.00% |
| 2021 | $1.00 | -33.33% |
| 2020 | $1.50 | 0.00% |
Pagos de dividendos de empresas similares o competidoras
| Empresa | Número de pagos de dividendos | País |
|---|---|---|
| 176.00% |
US
|
|
| 181.00% |
IE
|
|
| 87.00% |
US
|
|
| 0.00% |
US
|
|
| 8.00% |
DE
|
